253
Subscribers
No data24 hours
+17 days
+330 days
Posting time distributions
Data loading in progress...
Find out who reads your channel
This graph will show you who besides your subscribers reads your channel and learn about other sources of traffic.
Publication analysis
| Posts | Views | Shares | Views dynamics |
01 Fresh position has been recommended in "OptionTrade" for 13th May 2024. "Members" kindly check. | 16 | 0 | Loading... |
02 Fresh stock has been recommended in "BoSTML Stock" for 13th May 2024. "Members" kindly check. | 16 | 0 | Loading... |
03 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 16 | 0 | Loading... |
04 📝Cash & Derivatives Data as on 10th May 2024
📊India Vix : 18.47 [(+)1.50%]
➡️Cash DII : (+)2,709.81 cr
➡️Cash FII : (-)2,117.50 cr
➡️Index Futures FII : (-)212.79 cr
➡️Index Options FII : (-)5,060.18 cr
➡️Stock Futures FII : (+)1,942.28 cr
➡️Stock Options FII : (-)265.25 cr
➡️Index Options Calls FII :
➡️Index Options Puts FII :
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 16 | 0 | Loading... |
05 📝MOD for 13th May 2024
📊NIFTY
🔍View : Cautious
⚓️Expected Range : 21,900-22,100
🧮Pcr : 0.81
📌Max Pain : 21,850
🔗Net Contribution : (+)96.63
📊BANK NIFTY
🔍View : Cautious
⚓️Expected Range : 47,500 make or break level
🧮Pcr : 0.75
📌Max Pain : 47,800
🔗Net Contribution : (-)120.77
📃Securities in ban list :
1-Balrampurchini
2-Canbk
3-GMRInfra
4-HindCopper
5-Idea
6-PNB
7-Sail
8-Zeel
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 16 | 0 | Loading... |
06 Media files | 17 | 0 | Loading... |
07 Media files | 25 | 0 | Loading... |
08 Media files | 21 | 0 | Loading... |
09 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 31 | 0 | Loading... |
10 📝Cash & Derivatives Data as on 09th May 2024
📊India Vix : 18.20 [(+)6.56%]
➡️Cash DII : (+)5,642.53 cr
➡️Cash FII : (-)6,994.86 cr
➡️Index Futures FII : (-)3,882.15 cr
➡️Index Options FII : (+)17,667.35 cr
➡️Stock Futures FII : (-)3,084.97 cr
➡️Stock Options FII : (-)1,842.29 cr
➡️Index Options Calls FII :
➡️Index Options Puts FII :
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 29 | 0 | Loading... |
11 📝MOD for 10th May 2024
📊NIFTY
🔍View : Cautious
⚓️Expected Range : 21,800-22,200
🧮Pcr : 0.65
📌Max Pain : 22,050
🔗Net Contribution : (-)349.24
📊BANK NIFTY
🔍View : Cautious
⚓️Expected Range : 46,500/47,000-48,000
🧮Pcr : 0.69
📌Max Pain : 48,600
🔗Net Contribution : (-)623.97
📃Securities in ban list :
1-ABFRL
2-Balramchin
3-CanBk
4-GMRInfra
5-Idea
6-PEL
7-PNB
8-Sail
9-Zeel
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 23 | 0 | Loading... |
12 Media files | 27 | 0 | Loading... |
13 *First Time HDFc Bank as anchor Investor*⛳️🔥 | 27 | 0 | Loading... |
14 NFO - Baroda BNP Paribas Retirement Fund is open for subscription
Dear Valued Client,
Greetings from Agarwal & Associates!
We would like to inform you that Baroda BNP Paribas Mutual Fund has launched Baroda BNP Paribas Retirement Fund, an open-ended retirement solution-oriented scheme having a lock-in of 5 years or till retirement age (whichever is earlier). The Fund is open for subscription and will close on 22nd May 2024.
The primary investment objective of the Scheme is to generate income and capital appreciation by investing in a diversified portfolio of equity and equity related instruments and fixed income instruments with a view to provide a retirement solution to investors. The scheme will be benchmarked against CRISIL Hybrid 35+65 - Aggressive Index. | 28 | 0 | Loading... |
15 Fresh stock has been recommended in "BoSTML Stock" for 08th May 2024. "Members" kindly check. | 28 | 0 | Loading... |
16 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 29 | 0 | Loading... |
17 📝Cash & Derivatives Data as on 08th May 2024
📊India Vix : 17.08 [(+)0.43%]
➡️Cash DII : (+)5,928.81 cr
➡️Cash FII : (-)6,669.10 cr
➡️Index Futures FII :
➡️Index Options FII :
➡️Stock Futures FII :
➡️Stock Options FII :
➡️Index Options Calls FII :
➡️Index Options Puts FII :
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 28 | 0 | Loading... |
18 📝MOD for 09th May 2024
📊NIFTY
🔍View : Range bond
⚓️Expected Range : 22,000/22,200-22,400/22,500
🧮Pcr : 0.67
📌Max Pain : 22,400
🔗Net Contribution : (-)17.26
📊BANK NIFTY
🔍View : Indecisive
⚓️Expected Range : 48,000 make or break level
🧮Pcr : 0.82
📌Max Pain : 48,000
🔗Net Contribution : (-)354.67
📃Securities in ban list :
1-ABFRL
2-Balramchin
3-Biocon
4-CanBk
5-GMRInfra
6-Idea
7-PEL
8-PNB
9-Sail
10-Zeel
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 28 | 0 | Loading... |
19 Media files | 32 | 0 | Loading... |
20 TBO Tek Ltd
Subscribe
IPO Note
PRICE RANGE : Rs. 875 - Rs. 920
Leading Global Travel Distribution Platform
TBO Tek Ltd (TTL) is a B2B travel distribution platform that simplifies travel bookings for suppliers (hotels, airlines, car rentals, etc.) and buyers (travel agencies, independent travel advisors) through their two-sided technology platform. Founded in 2006, they operate in over 100 countries, offering a wide range of travel inventory, multi-currency support, and streamlining transactions between buyers and suppliers on their platform. The company has an established market position in the airline ticketing segment and the hotel segment. It currently services over 20,000 travel agents and has tie-ups with more than 7 lakh hotels across the globe
The global travel market is projected to grow to $2.6 trillion by 2027 from $1.9 trillion in 2023, with an 8.2% CAGR. Factors driving this growth include flexible work options, staycations, social media impact on travel discovery, and rising incomes in emerging economies.
TTL's platform boasts a high buyer retention rate, with 37% of buyers onboarded in FY17 continuing to transact with TTL in FY23, alongside a growing share of wallet indicated by the GTV per buyer of FY17 increasing by 5.3x in FY23.
The company's revenue surged from ₹142cr in FY21 to ₹1,065cr in FY23, marking a CAGR of 174% and highlighting a strong market presence and customer base expansion.
In FY23, TTL has shown robust financial growth, with its Profit After Tax (PAT) increasing by 340% YoY to Rs 148.5cr, while revenue from operations surged by 120% to Rs 1,064.6cr compared to the previous year.
At the upper price band of ₹920, TTL is available at a P/E ratio of 49x (based on FY24 EPS annualized), which seems to be reasonably priced.
Given robust recovery in travel and tourism industry worldwide, TTL is strategically positioned to bridge the gap in a fragmented market along with organic and inorganic growth strategies.
The Company has an asset light business model with a scalable platform and strong financials, we assign a "Subscribe" rating on a long-term basis. | 37 | 0 | Loading... |
21 NFO - HDFC Manufacturing Fund subscription closes on 10th May 2024
Dear Valued Client,
Greetings from Agarwal & Associates!
We would like to inform you that HDFC Mutual Fund has launched HDFC Manufacturing Fund, an open-ended equity scheme following the manufacturing theme. The subscription of the fund will close on 10th May 2024.
The objective of the fund is to provide long-term capital appreciation by investing predominantly in equity and equity related securities of companies engaged in the manufacturing activity. The core of the portfolio (at least 80%) will be invested in stocks that represent the diverse sectors of manufacturing. The well diversified portfolio will have stock selection from across market capitalization and will be based on bottom-up research ideas which are expected to have a long runway for growth. The performance of the scheme will be benchmarked against Nifty India Manufacturing Index (TRI). | 24 | 0 | Loading... |
22 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 31 | 0 | Loading... |
23 📝Cash & Derivatives Data as on 07th May 2024
📊India Vix : 17.01 [(+)2.45%]
➡️Cash DII : (+)2,304.50 cr
➡️Cash FII : (-)3,668.84 cr
➡️Index Futures FII : (-)1,772.24 cr
➡️Index Options FII : (-)1,131.12 cr
➡️Stock Futures FII : (-)137.29 cr
➡️Stock Options FII : (+)687.42 cr
➡️Index Options Calls FII :
➡️Index Options Puts FII :
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 36 | 0 | Loading... |
24 📝MOD for 08th May 2024
📊NIFTY
🔍View : Cautious
⚓️Expected Range : 22,000-22,400
🧮Pcr : 0.66
📌Max Pain : 22,400
🔗Net Contribution : (-)104.29
📊BANK NIFTY
🔍View : Indecisive
⚓️Expected Range : 48,000-48,500
🧮Pcr : 0.69
📌Max Pain : 48,500
🔗Net Contribution : (-)526.15
📃Securities in ban list :
1-ABFRL
2-Balramchin
3-Biocon
4-GMRInfra
5-Idea
6-PNB
7-Sail
8-Zeel
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 25 | 0 | Loading... |
25 Aadhar Housing Finance Ltd
Subscribe
IPO Note
PRICE RANGE : Rs. 300 - Rs. 315
A dominant player in low-income housing finance segment...
Aadhar Housing Finance Ltd (AHFL), incorporated in 2010, is one of the largest low-income housing finance companies in India servicing the home financing needs of the low-income sections of the society. Formed with the merger of DHFL Vysya and Aadhar Housing Finance, AHFL is one of the few players which has a pan-India presence.The average ticket size of loans is 10 lakhs with an average loan to value of 58.3% in December 2023. AHFL has served more than 246,983 customers through 471 branches and offices across the nation. BCP TOPCO VII PTE. LTD. (a Blackstone Group Company) is the holding company of Aadhar Housing Finance Ltd.
The Indian housing finance market saw a solid 14% CAGR from 2018 to 2023 and is expected to grow at 13-15% CAGR over FY23-26E driven by demand from smaller cities, attractive interest rates, and government support.
In FY23, AHFL boasted the highest number of active accounts and achieved the pinnacle in terms of Assets Under Management (AUM grew ~14% CAGR over FY21-23) and Net worth compared to its peers over the past three years (Source: CRISIL)
The declining average cost of borrowings from 8.2% in FY21 to 7.6% in 9MFY24 indicates improved profitability (~27% CAGR over FY21-23) and increased loan demand, fostering overall business growth.
The Net interest income (NII) grew by 26% YoY in FY23 while NIM (net interest margin) improved from 5.8% in FY21 to 8.0% in FY23 and 9% in 9MFY24.
AHFL enjoys strong RoE (return on equity) of ~18% in 9MFY24 vs 13.5% in FY21 and achieved collection efficiency of 100.5% in FY23 vs 99% in FY21 indicates its strong operational efficiency.The Capital adequacy ratio (CRAR) of AHFL is robust at 43% in FY23, indicates its strong liquidity position.
Furthermore, AHFL's strong parentage support from Blackstone Group have bolstered its relationships with financial institutions on the liability side, leading to evident enhancements in its resource profile.
At the upper price band of ₹315, AHFL is available at a P/BV of 2.6x (FY24E annualised), which appears to be reasonably priced compared to its peers.
Considering its leading position in HFC segment, strong promoter back up, pan India presence, strong growth in AUM & loan disbursements and Govt initiatives on affordable housing, we assign subscribe rating on medium to long term basis. | 36 | 0 | Loading... |
26 Fresh stock has been recommended in "BoSTML Stock" for 07th May 2024. "Members" kindly check. | 33 | 0 | Loading... |
27 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 33 | 0 | Loading... |
28 📝Cash & Derivatives Data as on 06th May 2024
📊India Vix : 16.60 [(+)13.56%]
➡️Cash DII : (+)781.39 cr
➡️Cash FII : (-)2,168.75 cr
➡️Index Futures FII : (+)535.73 cr
➡️Index Options FII : (-)11,508.25 cr
➡️Stock Futures FII : (+)167.10 cr
➡️Stock Options FII : (+)1,654.98 cr
➡️Index Options Calls FII : (-)41,218 qty (Bearish)
➡️Index Options Puts FII : (-)66,839 qty (Bullish)
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 32 | 0 | Loading... |
29 📝MOD for 07th May 2024
📊NIFTY
🔍View : Range bond
⚓️Expected Range : 22,300-22,600
🧮Pcr : 0.75
📌Max Pain : 22,500
🔗Net Contribution : (-)1.50
📊BANK NIFTY
🔍View : Range bond
⚓️Expected Range : 48,500-49,500
🧮Pcr : 0.74
📌Max Pain : 49,000
🔗Net Contribution : (+)151.29
📃Securities in ban list :
1-ABFRL
2-Balramchin
3-Biocon
4-GMRInfra
5-Idea
6-Sail
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 27 | 0 | Loading... |
30 Indegene Limited IPO open for subscription from 6th to 8th May 2024
We are pleased to inform you that the Initial Public Offering (IPO) Indegene Limited (IL), which specializes in delivering digital solutions to the life science sector, primarily focusing on biopharmaceutical companies as well as emerging biotech and medical device firms, is open for subscription from 6th May 2024 to 8th May 2024.
Key Points:
Price Band: Rs. 430 to Rs. 452 per share for a bid lot of 33 equity shares and its multiples thereafter
Face Value: Rs. 2 per equity share.
Issue Size: Rs. 1,789.11 crore - Rs. 1,841.76 crore comprising of a fresh issue of equity shares aggregating up to Rs. 760 crore and an offer for sale of equity shares aggregating up to 2,39,32,732 equity shares.
At the upper price band of Rs. 452, IL is available at a P/E ratio of 34x (based on FY24 EPS annualized), which seems to be reasonably priced. Given its post-IPO debt-free status, along with organic and inorganic growth strategies and capex plans, the company is strategically positioned to leverage industry growth and maintain its strong financial and operational track record within its niche market. Therefore, Agarwal & Associates assigns a “SUBSCRIBE” rating on a long-term basis. | 28 | 0 | Loading... |
31 Fresh stock has been recommended in "BoSTML Stock" for 06th May 2024. "Members" kindly check. | 32 | 0 | Loading... |
32 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 33 | 0 | Loading... |
33 📝Cash & Derivatives Data as on 03rd May 2024
📊India Vix : 14.62 [(+)8.72%]
➡️Cash DII : (+)690.52 cr
➡️Cash FII : (-)2,391.98 cr
➡️Index Futures FII : (-)4,419.22 cr
➡️Index Options FII : (-)4,309.89 cr
➡️Stock Futures FII : (-)8,189.55 cr
➡️Stock Options FII : (+)1,140.37 cr
➡️Index Options Calls FII : (-)92,426 qty (Bearish)
➡️Index Options Puts FII : (-)23,377 qty (Bullish)
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 38 | 0 | Loading... |
34 📝MOD for 06th May 2024
📊NIFTY
🔍View : Short covering can come
⚓️Expected Range : 22,300 strong support
🧮Pcr : 0.79
📌Max Pain : 22,800
🔗Net Contribution : (-)178.88
📊BANK NIFTY
🔍View : Short covering can come
⚓️Expected Range : 48,500 strong support
🧮Pcr : 0.76
📌Max Pain : 49,000
🔗Net Contribution : (-)307.13
📃Securities in ban list :
1-ABFRL
2-Balramchin
3-Biocon
4-GMRInfra
5-Idea
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 33 | 0 | Loading... |
35 Media files | 31 | 0 | Loading... |
36 Report Card 2024-25 | 38 | 0 | Loading... |
37 Indegene Ltd
Subscribe
IPO Note
PRICE RANGE : Rs. 430 - Rs. 452
A Pioneer in Digital Life Sciences Solutions...
Indegene Ltd. (IL), founded in 1998, specializes in delivering digital solutions to the life science sector, primarily focusing on biopharmaceutical companies as well as emerging biotech and medical device firms. IL provides comprehensive support across various critical areas, including drug development, clinical trials, pharmacovigilance, regulatory submissions, compliance management, product launches, and sales and marketing endeavours. Over the years, IL has completed a total of 13 acquisitions, benefiting from synergies with each acquisition. As of December 31, 2023, the company had 65 active clients, managed from six operational hubs and 17 strategically located offices across North America, Europe, and Asia.
The company is well positioned to capitalize on the growth in life sciences operations spending, which was estimated at ₹12.0 trillion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% to reach ₹15.5 trillion by 2026.
IL is backed by private equity firms, including C.A Dawn Investments (Carlyle Group), which holds a 20.8% stake, while Nadathur Fareast Pte. Ltd. (Nadathur Group) and Brighton Park Capital Fund own 23.6% and 12% stakes, respectively.
Indegene derives 59% of its revenue from the Enterprise Commercial Solutions segment and 12% from Omnichannel Activation Solutions. Both segments cater to the commercial needs of life sciences companies.
IL has established client relationships with the top 20 biopharmaceutical companies globally in terms of revenue for FY23. These clients contributed over 69% of revenue in each of the fiscal years spanning FY21-23.
The company's revenue, EBITDA, and PAT grew at a CAGR of 54.5%, 31.1%, and 19.7%, respectively, over FY21-FY23. The average EBITDA margin and PAT margin stand at around 19% and 14%, showcasing a strong financial and margin profile during the period.
As of 9MFY24, the total debt stands at ₹399cr, with a debt/equity ratio of 0.3x. By utilizing approximately 52% of the IPO proceeds for debt repayment, the company can become debt-free.
At the upper price band of ₹452, IL is available at a P/E ratio of 34x (based on FY24 EPS annualized), which seems to be reasonably priced.
Given its post-IPO debt-free status, along with organic and inorganic growth strategies and capex plans, the company is strategically positioned to leverage industry growth and maintain its strong financial and operational track record within its niche market.
Therefore, we assign a "Subscribe" rating on a long-term basis. | 48 | 0 | Loading... |
38 Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates | 45 | 0 | Loading... |
39 📝Cash & Derivatives Data as on 02nd May 2023
📊India Vix : 13.44[(+)4.47%]
➡️Cash DII : (+)1,352.44 cr
➡️Cash FII : (-)964.47 cr
➡️Index Futures FII : (+)363.63 cr
➡️Index Options FII : (-)22,053.22 cr
➡️Stock Futures FII : (+)5,163.11 cr
➡️Stock Options FII : (+)115.77 cr
➡️Index Options Calls FII : (-)1,24,878 qty (Bearish)
➡️Index Options Puts FII : (-)1,08,125 qty (Bullish)
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 45 | 0 | Loading... |
40 📝MOD for 03rd May 2024
📊NIFTY
🔍View : Positive
⚓️Expected Range : 22,600 strong support
🧮Pcr : 1.05
📌Max Pain : 22,650
🔗Net Contribution : (+)26.99
📊BANK NIFTY
🔍View : Positive
⚓️Expected Range : 49,000 strong support
🧮Pcr : 0.85
📌Max Pain : 50,000
🔗Net Contribution : (-)123.67
📃Securities in ban list :
1-ABFRL
2-Biocon
3-IDEA
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062 | 40 | 0 | Loading... |
Fresh position has been recommended in "OptionTrade" for 13th May 2024. "Members" kindly check.
Fresh stock has been recommended in "BoSTML Stock" for 13th May 2024. "Members" kindly check.
Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates
📝Cash & Derivatives Data as on 10th May 2024
📊India Vix : 18.47 [(+)1.50%]
➡️Cash DII : (+)2,709.81 cr
➡️Cash FII : (-)2,117.50 cr
➡️Index Futures FII : (-)212.79 cr
➡️Index Options FII : (-)5,060.18 cr
➡️Stock Futures FII : (+)1,942.28 cr
➡️Stock Options FII : (-)265.25 cr
➡️Index Options Calls FII :
➡️Index Options Puts FII :
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062
View Agarwal N Associates's Catalog on WhatsApp
Learn more about their products & services
Photo unavailableShow in Telegram
📝MOD for 13th May 2024
📊NIFTY
🔍View : Cautious
⚓️Expected Range : 21,900-22,100
🧮Pcr : 0.81
📌Max Pain : 21,850
🔗Net Contribution : (+)96.63
📊BANK NIFTY
🔍View : Cautious
⚓️Expected Range : 47,500 make or break level
🧮Pcr : 0.75
📌Max Pain : 47,800
🔗Net Contribution : (-)120.77
📃Securities in ban list :
1-Balrampurchini
2-Canbk
3-GMRInfra
4-HindCopper
5-Idea
6-PNB
7-Sail
8-Zeel
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062
Disclaimer: All above levels given are as per my view kindly consult your financial advisor before initiating any trades. We are not responsible for any profit or loss.
Regards : Agarwal & Associates
📝Cash & Derivatives Data as on 09th May 2024
📊India Vix : 18.20 [(+)6.56%]
➡️Cash DII : (+)5,642.53 cr
➡️Cash FII : (-)6,994.86 cr
➡️Index Futures FII : (-)3,882.15 cr
➡️Index Options FII : (+)17,667.35 cr
➡️Stock Futures FII : (-)3,084.97 cr
➡️Stock Options FII : (-)1,842.29 cr
➡️Index Options Calls FII :
➡️Index Options Puts FII :
📲For advisory services contact : 9830778062
📒For services catalogue kindly visit : https://wa.me/c/919830778062
View Agarwal N Associates's Catalog on WhatsApp
Learn more about their products & services